We have negotiated special hotel / motel room rates.  Rates are on a room only basis – except for Rendezous (includes breakfast) and  GST.  A minimum of one night’s accommodation must be prepaid at the time of your booking and the balance / incidentals paid direct to hotel / motel on departure.   All cancellations made 30 days prior to arrival may incur cancellation fees.

Rydges Latimer Hotel Christchurch
30 Latimer Square
Christchurch (city centre)
There are plenty of buses that run from the city centre past St Margaret’s College – approx 12 min bus ride

Rating: Superior
Room rate: $204.00 per night (1 or 2 persons)
Rydges Latimer is just two blocks from Cathedral Square and 5 mins walk to the Transitional Cathedral (where the conference dinner is being held).
All rooms have ensuite and the usual facilitates you would expect of a superior hotel including high-speed broadband access.

Rendezvous Hotel Christchurch

166 Gloucester Street
Christchurch (city centre)
There are plenty of buses that run from the city centre past St Margaret’s College – approx 12 min bus ride

Rating: Superior
Room rate: Run of house $165.00 per night including breakfast (1 person) – $185.00 per night including breakfast (2 persons)

Rendezvous Hotel Christchurch is just one block from Cathedral Square.  All rooms have ensuite and the usual facilities you would expect of a superior hotel including high-speed broadband access.

Ashford Motor Lodge
35 Papanui Road
Christchurch (5 min walk to St Margaret’s College)

Rating: Moderate
Room rates: One bedroom & superior studio units $159.50 per night (up to 2 persons)
Two bedroom suite $214.50 per night (up to 4 persons)

Ashford Motor Lodge offers friendly service and great location for St Margaret’s College and also within walking distance to the city.


Pavilions Hotel Christchurch
42 Papanui Road
Christchurch (5 min walk to St Margaret’s College)

Rating: Moderate
Room rates: Standard room $155.00 per night
Executive room $170.00 per night

All rooms have ensuite and the usual facilities.  On site bar and restaurant and great location for St Margaret’s College and also within walking distance to the city.


Heartland Hotel Cotswold
88 Papanui Road
Christchurch (7 min walk to St Margaret’s College)

Room rates: Studio room $170.00 per night
One bedroom suite $190.00 per night

All rooms have the usual facilities.  On site bar and restaurant and great location for St Margaret’s College and also within walking distance to the city.

Keynote Speakers

Prof. Shaheen Mehtar

Sponsored by

Prof Shaheen Mehtar is an Emeritus Professor at the Unit for Infection Prevention and Control (UIPC),  Faculty of Medicine & Health Sciences, Stellenbosch University. She trained in the United Kingdom in Medical Microbiology, and was Head of Microbiology at the North Middlesex Hospital & Senior Lecturer at Royal Free Hospital until 2000 when, she moved to South Africa.  In 2004 established the Unit of Infection Prevention and Control, Tygerberg Hospital & Stellenbosch Uni, and has trained more than 1000 students ranging from basic courses to a Masters in IPC across 34 countries in Africa.

She is an internationally recognised expert in IPC and has been instrumental in setting up IPC programmes globally. She served on the executive committees of HIS, BSAC, ESCMID, ISC and ISID. She serves on several WHO committees for global IPC policies.

Shaheen is a founder member, and Past Chair, of the Infection Control Africa Network (ICAN) through which she is involved in IPC, WASH and AMR training across Africa and setting up national IPC structures in 8 African countries. She was actively involved in Sierra Leone during the Ebola outbreak. She has published extensively (170 papers), authored two books and several chapters.

Julie Storr RGN BNurse MBA

Authentic leadership and the future of IPC

This session will focus on leadership for effective IPC with a special exploration of authentic leadership theory and its relevance to the infection preventionist. To support our understanding of what makes an effective IPC leader, the session will explore relevant literature on leadership challenges and opportunities including how to build capacity and capability. The session will draw on current thinking that shaped recent WHO IPC and quality handbooks and training resources – resources that support those responsible for leading the development and implementation of national and health care facility IPC and quality activities, policies, strategies and operational plans. The session will conclude with some personal reflections on a leadership journey in the quest for high quality people-centered IPC.

Patient empowerment 1999-2019

The role of patient empowerment in the prevention and control of infection has been on the table for over twenty years and has been described as a critical element of hand hygiene promotion. It has also been the subject of much academic debate with many questioning its value and feasibility. 2019 marks the twentieth anniversary of my own personal journey into patient empowerment and this session will look back on what has been learned since 1999. I will argue that the concept is perhaps, to some extent, misunderstood and will put forward the case that, as part of a multimodal strategy it can add tremendous value to the quest for zero avoidable infections and enhanced health related quality of life for patients.

 Julie is a graduate nurse from the University of Manchester, where she also trained as a Health Visitor and more recently studied for an MBA. Julie is a director at S3 Global and has over a decade of experience working with WHO on the development, implementation and evaluation of global improvement programmes in the field of patient safety, quality and infection prevention and control, with a focus on behaviour change. Julie has worked with WHO units focused on Water Sanitation and Health (WASH), Quality Systems and Resilience and Global Infection Prevention and Control (IPC). Her technical and leadership expertise was called on to support WHO’s Ebola response and recovery efforts in 2014/15, with a focus on national IPC policy development in Sierra Leone. She has led on the development of evidence based WHO Guidelines (Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level, 2016) and implementation support packages (Core Components and CRO). She was previously President of the Infection Prevention Society of the UK and Ireland, Assistant Director at the English National Patient Safety Agency and Director of the seminal cleanyourhands campaign. Julie has authored a book (Perspectives and Perceptions of IPC – highly commended at the 2016 BMA Medical Book Awards), published widely in the academic literature and is currently writing a follow up book focused on IPC and the social sciences. She is peer reviewer of a range of academic journals. One of her recent papers on infection prevention and control and universal health coverage and quality was awarded research paper of the year in the Journal of Research in Nursing in 2017. She is currently studying for a doctorate in public health (health care leadership and management) at Johns Hopkins Bloomberg School of Public Health, Baltimore.

Siouxsie Wiles – Microbiologist

Sponsored by 

Dr Siouxsie Wiles is an award-winning scientist who has made a career of manipulating microbes. She still can’t quite believe she gets paid to do this for a living.
Siouxsie is an Associate Professor at the University of Auckland where she and her team make bacteria glow in the dark to understand how infectious microbes make us sick and to find new medicines. She is also an enthusiastic tweeter, blogger, artist, curator and media science commentator and has won numerous prizes for her efforts, including the Prime Minister’s Science Media Communication Prize and the Royal Society Te Apārangi’s Callaghan Medal.
In 2016, Siouxsie was named a Blake Leader by the Sir Peter Blake Trust, and in 2018 was one of three finalists for the Kiwibank New Zealander of Year award. She recently published her first book, ‘Antibiotic resistance: the end of modern medicine?
2019 New Year’s Honours list she was made a member of the New Zealand Order of Merit for services to microbiology and science communication.

Prof. Mary-Louise McLaws

Sponsored by 

Mary-Louise is Professor of Epidemiology, Healthcare Associated Infection and Infectious Diseases Control at The University of New South Wales (UNSW) Australia, the Water-Health Leader for the UNSW Global Water Institute and Deputy President of the UNSW Academic Board. Her clinical epidemiology research is focused in patient safety improvement programs.
Mary-Louise has focused her research program on surveillance and hand hygiene. She performed the first Australian prevalence survey healthcare associated infections in the mid-1980s and went on to develop the first standardised semi-automated surveillance system for healthcare associated infections on behalf of the NSW Ministry of Health. In the mid-2000s she was the WHO Advisor to China and Malaysia for the development of their national HAI surveillance systems. She was a contributor to the WHO Guidelines for Hand Hygiene and an advisor to the WHO First Global Patient Safety Challenge: Clean Care is Safer Care project. Mary-Louise holds membership to the World Health Organization (WHO) Technical Steering Committee for the Infection Prevention and Control Global Unit.
As honorary epidemiologist to NSW Clinical Excellence Commission she collaborated on the first Australian hand hygiene intervention Clean Care Saves Live that preceded the national program while supervising early Australian behavioural aspects of hand hygiene intervention. She also collaborated on the NSW Clinical Excellence Commission CLABSI intervention that aimed at reducing central line associated infections in 32 intensive care units by introducing an aseptic insertion approach. This was adopted by ANZICS and rolled out nationally. She also collaborated on the Sepsis Kills intervention that aimed at early detection and treatment of sepsis in 32 emergency departments. This intervention saved over 200 lives and was awarded the Global Sepsis Alliance in the Government Category and in 2017 the Medical Journal of Australia/MDA awarded the publication Best Research Paper.
Post-SARS she collaborated with the Health Bureau to review the response to the outbreak in Beijing. In preparation of pandemic influenza the Chief Medical Officer appointed Mary-Louise to review the Australian Infection Prevention Guidelines for Healthcare Workers for evidence-based recommendations. Her capacity building in patient safety in low-medium resource settings includes ICU projects in Turkey, haemodialysis in Vietnam, hand hygiene for crowded healthcare settings in Vietnam, needlestick injury surveillance in Taiwan, water-related health in Vanuatu and Mali and understanding antibiotic prescribing practices and use of antibiotic in the community and food animals in Cambodia.
Her most recent projects have contested the reliability and validity of the human auditing used in the Australian national hand hygiene program against automation and clinicians’ behaviour around compliance.

Silver Sponsors

EBOS Healthcare

EBOS Healthcare is a leading supplier of high quality medical products, equipment and consumables to Hospital and Tertiary care providers. Aside from being a New Zealand company, a dedicated clinical product specialist team ensures high calibre sales support and follow up and ensures that we continue to grow as the market leader in the Hospital sector.
Infection Prevention is a key strategic category that EBOS focus on having flagship brands such as the SC Johnson’s Cutan Medical Skin care range, Vernacare Human Waste Management System, Halyard Health Gowns, Masks & Fluid Absorption range and Ansell Gloves.
The SC Johnson’s  Cutan range is the dedicated Healthcare range with world first Alcohol Foam technology and dispenser technology.  The range includes the Enhanced Alcohol Foam hand sanitiser, Hand Soap and Moisturising cream. All products can be used in wall mount, colour coded dispensers with Biocote technology.




Whiteley Medical is a leading global innovator of surface disinfectants and detergents in Australia and New Zealand. Our comprehensive range of Infection Prevention & Control products suit a wide range of cleaning applications. Our long-term commitment to research and innovation has seen Whiteley Medical recently launch the world’s first dry surface biofilm remover – Surfex®. It’s the result of collaborative research with Western Sydney University and Macquarie University on Dry Surface Biofilms. Biofilms are present in the environment and many pose real risks to the public. For more information on the latest Infection Control Solutions visit the Whiteley Medical stand at IPCNC in Christchurch.


Bronze Sponsors

Reynard Health Supplies


Reynard Health Supplies is a dynamic company specialising in the manufacturing and distribution of the highest quality and most cost-effective consumable products within the healthcare market.  We are New Zealand’s leading Supplier of Surface Cleaning Wipes and Skin Care Wipes within the DHB and Aged Care sectors.
Robin Ferguson – Managing Director
Reynard Health Supplies
7 Napier Road
P O Box 8470
Havelock North 4157
Ph: 0508 494 737



GOJO Australasia Pty Limited

GOJO is the leading global manufacturer of skin health and hygiene solutions for away-from-home settings. Our PURELL Gel and Foam Hand Sanitisers is the only globally approved formula with an efficacious dosage of 1.1ml. Our  healthcare specific Mild Hand Wash is free of MI, MCI and MIT, which are commonly used harsh preservatives that can cause skin irritations. Please drop by the GOJO Stand for a free sample.


Tristel is the only company in the world to combine its proprietary chlorine dioxide formulation with innovative packaging for high-performance disinfection of medical devices.
Tristel Duo NCU is an intermediate-level disinfectant for non-critical ultrasound probes and equipment, proven effective in 30 seconds, and the only disinfectant that treats all parts of an ultrasound unit the same.
Tristel Duo OPH is an Instrument Grade High Level Disinfectant that meets the regulatory standards whilst ensuring the highest possible microbiological efficacy and material compatibility, and proven effective in two minutes.
Find out more on stand 15.

Waste Management

Waste Management is proudly the leading sharps safety and waste management service provider to the NZ healthcare sector. Waste Management provides an integrated service offering, expertise in understanding risk, regulations and compliance governing the healthcare sector. Exclusive distributors of the Daniels Sharpsmart reusable sharps system, which continues to provide best in market sharps management safety for healthcare staff.

BSN Medical


BSN medical is a global leader in the medical device sector, specialising in the areas of Wound Management,  Orthopaedics, Vascular Therapy and Lymphoedema.
We are focused on developing and providing first class products and services to help deliver improved healthcare outcomes for the healing of bone, skin, soft tissue and lymphatic and vascular conditions.
Our product range includes many well-known and trusted brands including Leukomed®, Propax®, Cutimed®, JOBST®, Fixomull® and Leuko® Tapes.

Lohmann & Rauscher


Lohmann & Rauscher (L&R) is a leading manufacturer of high-quality, innovative wound management, compression and immobilisation products as well as operating room consumables and apparel. We develop customised solutions for the problems faced by patients and healthcare professionals – from classic wound dressing material to modern therapy and patient care systems.
With 4,600 employees, 44 corporate subsidiaries and holdings in 24 countries and more than 130 selected partners, L&R is active in over five continents and in all of the world’s key markets

Contact Details
Address: Suite G03, 321 Ferntree Gully Road, Mt Waverley, Victoria, 3149, Australia
Phone (AUS):  1300 572 869
Phone (NZ): 0800 572 869
Fax (ANZ) : +61 3 8840 0401



BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has 65,000 employees and a presence in virtually every country around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

Global Medics Group

The Global Medics Group is a young dynamic team focused on “Infection Control” in all areas of Healthcare for both Patients and Healthcare providers to reduce (HAI’s) Hospital acquired infections and (SSI’s) Surgical Site Infections.
A major challenge in modern healthcare today is reducing the spread of contamination. Using these products, Clinell Universal disinfection/detergent wipes, InControl Cuff First Nitrile Gloves, InControl Quik-Fit Disposable Cubicle Curtains, Disposable Pulp Receptacles, Patient wipes, Disposable linen will help stop cross contamination in its tracks.

Free Phone – 0800 456633

Web – /

Email –


Diversey’s purpose is to protect and care for people every day. Diversey has been, and always will be, a pioneer and facilitator for life. We constantly deliver revolutionary cleaning and hygiene technologies that provide total confidence to our customers across all of our global sectors, including: cleaning products, systems and services that efficiently integrate chemicals, machines and sustainability programs. This makes us unique among leading global hygiene and cleaning companies. Everything we do has our customers’ needs at its heart and is based on the belief that cleaning and hygiene are life essentials. With over 95 years of expertise, we safeguard our customers’ businesses, contributing to productivity improvements, lower total operating costs and brand protection. Headquartered in Fort Mill, South Carolina, USA, Diversey employs approximately 9,000 people globally, generating net sales of approximately $2.6 billion in 2017.

For more information, visit or follow us on social media.